The relationship between oxidized lipoprotein(a) and carotid atherosclerosis in asymptomatic subjects: A comparison with native lipoprotein(a)

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Kotani, Kazuhiko ^a   Yamada, Shingo ^b   Yamada, Toshiyuki ^a   Taniguchi, Nobuyuki ^a   Sakurabayashi, Ikunosuke ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SHINO TEST CORPORATION   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LIPOPROTEIN A;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JAPANESE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; SYSTOLIC BLOOD PRESSURE; AGE; BLOOD; BODY MASS; CAROTID ARTERY DISEASE; CHEMISTRY; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; HYPERTENSION; JAPAN; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; JAPAN; LIPOPROTEIN(A); MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 80053513290     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-174     Document Type: Article

References (19)

1. Oxidized LDL and coronary heart disease. Holvoet P, Acta Cardiol 2004 59 479 484 10.2143/AC.59.5.2005219 15529550 (Pubitemid 39331216)
2. Lipoprotein(a) as a risk factor for coronary artery disease. Marcovina SM, Koschinski ML, Am J Cardiol 1998 82 57 66 10.1016/S0002-9149(98)00954-0 (Pubitemid 29047617)
3. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J, JAMA 2009 302 412 423 19622820
4. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB, N Engl J Med 2005 353 46 57 10.1056/NEJMoa043175 16000355 (Pubitemid 41007806)
5. Development of antibody against epitope of lipoprotein(a) modified by oxidation: evaluation of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a). Yamada S, Morishita R, Nakamura S, Ogihara T, Kusumi Y, Sakurai I, Kubo N, Sakurabayashi I, Circulation 2000 102 1639 1644 11015341
6. Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vasucular wall. Morishita R, Ishii J, Kusumi Y, Yamada S, Komai N, Ohishi M, Nomura M, Hishida H, Niihashi M, Mitsumata M, J Atheroscler Thromb 2009 16 410 418 10.5551/jat.No224 19672030
7. The association between blood glucose and oxidized lipoprotein(a) in healthy young women. Kotani K, Yamada S, Uurtuya S, Yamada T, Taniguchi N, Sakurabayashi I, Lipids Health Dis 2010 9 103 20858228
8. Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques. Umahara T, Uchihara T, Yamada S, Hashimoto T, Akimoto J, Haraoka J, Iwamoto T, Atherosclerosis 2011 215 392 398 10.1016/j.atherosclerosis.2010.10.048 21300353
9. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. Zioncheck TF, Powell LM, Rice GC, Eaton DL, Lawn RM, J Clin Invest 1991 87 767 771 10.1172/JCI115079 1825665
10. Induction of oxygen free radical generation in human monocytes by lipoprotein(a). Riis-Hansen P, Kharazmi A, Jauhiainen M, Ehnholm C, Eur J Clin Invest 1994 24 497 499 7957508 (Pubitemid 2102513)
11. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Galle J, Bengen J, Schollmeyer P, Wanner C, Circulation 1995 92 1582 1589 7664444
12. Native and gamma radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium. Beaudeux JL, Césarini ML, Gardès-Albert M, Maclouf J, Merval R, Esposito B, Peynet J, Tedqui A, Atherosclerosis 1997 132 29 35 10.1016/S0021-9150(97)00073-7 9247356 (Pubitemid 27306736)
13. Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. Ren S, Man RY, Angel A, Shen GX, Atherosclerosis 1997 128 1 10 10.1016/S0021-9150(96) 05971-0 9051192 (Pubitemid 27065255)
14. Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells. Komai N, Morishita R, Yamada S, Oishi M, Iguchi S, Aoki M, Sasaki M, Sakurabayashi I, Higaki J, Ogihara T, Hypertension 2002 40 310 314 10.1161/01.HYP.0000029974.50905.B4 12215472 (Pubitemid 35006716)
15. Metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. Kawamoto R, Tomita H, Oka Y, Ohtsuka N, Kamitani A, J Atheroscler Thromb 2005 12 268 275 10.5551/jat.12.268 16205023
16. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M, Circulation 2007 115 459 467 10.1161/CIRCULATIONAHA.106. 628875 17242284 (Pubitemid 46184197)
17. A new Lp(a) assay that is unaffected by apo(a) size polymorphism. Yamada S, Inoue K, Morishita R, Ogihara T, Kubono K, Kubo N, Abe A, Sakurabayashi I, Clin Chim Acta 1999 287 29 43 10.1016/S0009-8981(99)00119-9 10509894 (Pubitemid 29413007)
18. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, Nagoh N, Kayaba K, Yamada S, Matsuo H, Hosoe M, Itoh Y, Kawai T, Igarashi M, Shimada K, Am J Cardiol 1995 76 928 932 10.1016/S0002-9149(99)80263-X 7484833
19. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. Madamanchi NR, Hakim ZS, Runge MS, J Thromb Haemost 2005 3 254 267 10.1111/j.1538-7836.2004.01085.x 15670030 (Pubitemid 41623612)